Benefits of Nicotinamide Riboside Upon Cognition and Sleep
NCT05500170
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Poor sleep quality and short sleep duration may be a mechanistic component of cognitive impairment in older adults, associated with a decline in brain-derived neurotrophic factor. Increasing the availability of nicotinamide adenine dinucleotide (NAD+) with supplementation of its precursor, nicotinamide riboside (NR), a form of vitamin B3 may increase the expression of brain-derived neurotrophic factor.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cognitive Impairment
- Sleep Quality
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 65 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- State University of New York at Buffalo
- Last updated on ClinicalTrials.gov
- September 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Buffalo Veteran Affairs Medical Center · Buffalo, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.